{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:51:02Z","timestamp":1792497062731,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["18-671"],"award-info":[{"award-number":["18-671"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009193","name":"Royal Society of New Zealand Marsden Fund","doi-asserted-by":"publisher","award":["17-064"],"award-info":[{"award-number":["17-064"]}],"id":[{"id":"10.13039\/501100009193","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.coph.2022.102345","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T06:57:46Z","timestamp":1672988266000},"page":"102345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Recent advances in emerging PCOS therapies"],"prefix":"10.1016","volume":"68","author":[{"given":"Kelly A.","family":"Glendining","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0309-532X","authenticated-orcid":false,"given":"Rebecca E.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2022.102345_bib1","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102345_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.coph.2022.102345_bib3","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/humrep\/deac091","article-title":"Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990-2019","volume":"37","author":"Safiri","year":"2022","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102345_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"110","author":"Teede","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.coph.2022.102345_bib5","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102345_bib6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.coph.2022.102345_bib7","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.coph.2022.102345_bib8","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/aogs.12706","article-title":"Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes","volume":"94","author":"Aziz","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.coph.2022.102345_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13093","article-title":"The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome","volume":"34","author":"McCartney","year":"2022","journal-title":"J\u00a0Neuroendocrinol"},{"key":"10.1016\/j.coph.2022.102345_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coemr.2020.04.005","article-title":"Abnormal GnRH pulsatility in polycystic ovary syndrome: recent insights","volume":"12","author":"McCartney","year":"2020","journal-title":"Curr Opin Endocr Metab Res"},{"key":"10.1016\/j.coph.2022.102345_bib11","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.fertnstert.2008.02.092","article-title":"Drugs in infertility and fetal safety","volume":"89","author":"Elizur","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.coph.2022.102345_bib12","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/humrep\/det323","article-title":"Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort","volume":"28","author":"Brinton","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102345_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome","volume":"41","author":"Stener-Victorin","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.coph.2022.102345_bib14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/humrep\/deaa357","article-title":"Early initiation of anti-androgen treatment is associated with increased probability of spontaneous conception leading to childbirth in women with polycystic ovary syndrome: a population-based multiregistry cohort study in Sweden","volume":"36","author":"Elenis","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102345_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1210\/en.2018-00966","article-title":"A\u00a0hyperandrogenic environment causes intrinsic defects that are detrimental to follicular dynamics in a PCOS mouse model","volume":"160","author":"Bertoldo","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2022.102345_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.neuropharm.2007.01.022","article-title":"Steroid modulation of GABAA receptor-mediated transmission in the hypothalamus: effects on reproductive function","volume":"52","author":"Henderson","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.coph.2022.102345_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1210\/jc.2017-01186","article-title":"Combined oral contraception and Bicalutamide in polycystic ovary syndrome and severe hirsutism: a double-blind randomized controlled trial","volume":"103","author":"Moretti","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102345_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clgc.2018.07.017","article-title":"Clinical development of Darolutamide: a novel androgen receptor antagonist for the treatment of prostate cancer","volume":"16","author":"Fizazi","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.coph.2022.102345_bib19","doi-asserted-by":"crossref","first-page":"E3334","DOI":"10.1073\/pnas.1616467114","article-title":"Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome","volume":"114","author":"Caldwell","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102345_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.coph.2022.102345_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105554","article-title":"Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia","volume":"198","author":"Guarnotta","year":"2020","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.coph.2022.102345_bib22","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1096\/fj.201701263RR","article-title":"Maternal androgen excess and obesity induce sexually dimorphic anxiety-like behavior in the offspring","volume":"32","author":"Manti","year":"2018","journal-title":"Faseb J"},{"key":"10.1016\/j.coph.2022.102345_bib23","doi-asserted-by":"crossref","first-page":"bvac037","DOI":"10.1210\/jendso\/bvac037","article-title":"11-Oxyandrogens in adolescents with polycystic ovary syndrome","volume":"6","author":"Taylor","year":"2022","journal-title":"J\u00a0Endocr Soc"},{"key":"10.1016\/j.coph.2022.102345_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","article-title":"Sex hormone binding globulin - an important biomarker for predicting PCOS risk: a systematic review and meta-analysis","volume":"64","author":"Deswal","year":"2018","journal-title":"Syst Biol Reprod Med"},{"key":"10.1016\/j.coph.2022.102345_bib25","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tig.2022.01.005","article-title":"Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges","volume":"38","author":"Wang","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.coph.2022.102345_bib26","article-title":"Polycystic ovary syndrome susceptibility loci inform disease etiological heterogeneity","volume":"10","author":"Zhang","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.coph.2022.102345_sref27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41591-020-0751-5","article-title":"Using human genetics to understand the disease impacts of testosterone in men and women","volume":"26","author":"Ruth","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2022.102345_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.coph.2022.102345_bib29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2022.102345_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fendo.2012.00048","article-title":"New insights into the control of pulsatile GnRH release: the role of Kiss1\/neurokinin B neurons","volume":"3","author":"Navarro","year":"2012","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.coph.2022.102345_bib31","doi-asserted-by":"crossref","first-page":"E10216","DOI":"10.1073\/pnas.1713897114","article-title":"Definition of the hypothalamic GnRH pulse generator in mice","volume":"114","author":"Clarkson","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102345_bib32","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.1834399100","article-title":"Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54","volume":"100","author":"de Roux","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2022.102345_bib33","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJMoa035322","article-title":"The GPR54 gene as a regulator of puberty","volume":"349","author":"Seminara","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.coph.2022.102345_bib34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng.306","article-title":"TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction","volume":"41","author":"Topaloglu","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.coph.2022.102345_sref35","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1172\/JCI139681","article-title":"Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders","volume":"130","author":"Abbara","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2022.102345_bib36","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/jc.2016-1202","article-title":"Neurokinin B receptor antagonism in women with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"101","author":"George","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102345_bib37","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/humrep\/deaa104","article-title":"Kisspeptin and neurokinin B interactions in modulating gonadotropin secretion in women with polycystic ovary syndrome","volume":"35","author":"Skorupskaite","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.coph.2022.102345_bib38","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab020","article-title":"Neurokinin 3 receptor antagonism ameliorates key metabolic features in a hyperandrogenic PCOS mouse model","volume":"162","author":"Sucquart","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2022.102345_sref39","doi-asserted-by":"crossref","first-page":"e3519","DOI":"10.1210\/clinem\/dgab320","article-title":"Randomized controlled trial of neurokinin 3 receptor antagonist fezolinetant for treatment of polycystic ovary syndrome","volume":"106","author":"Fraser","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102345_bib40","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000495889","article-title":"Neurokinin 3 receptor antagonism: a novel treatment for menopausal hot flushes","volume":"109","author":"Modi","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.coph.2022.102345_bib41","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1210\/en.2013-1331","article-title":"Kisspeptin, neurokinin B, and dynorphin act in the arcuate nucleus to control activity of the GnRH pulse generator in ewes","volume":"154","author":"Goodman","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2022.102345_bib42","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1210\/clinem\/dgab602","article-title":"Inhibiting Kiss1 neurons with kappa opioid receptor agonists to treat polycystic ovary syndrome and vasomotor symptoms","volume":"107","author":"McCarthy","year":"2022","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102345_bib43","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1507\/endocrj.EJ20-0832","article-title":"Reduction of arcuate kappa-opioid receptor-expressing cells increased luteinizing hormone pulse frequency in female rats","volume":"68","author":"Dai","year":"2021","journal-title":"Endocr J"},{"key":"10.1016\/j.coph.2022.102345_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23063118","article-title":"Kappa-opioid receptor blockade ameliorates obesity caused by estrogen withdrawal via promotion of energy expenditure through mTOR pathway","volume":"23","author":"Romero-Pico","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coph.2022.102345_bib45","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab056","article-title":"Humanin alleviates insulin resistance in polycystic ovary syndrome: a human and rat model-based study","volume":"162","author":"Wang","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2022.102345_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/molehr\/gaaa081","article-title":"Humanin regulates oxidative stress in the ovaries of polycystic ovary syndrome patients via the Keap1\/Nrf2 pathway","volume":"27","author":"Wang","year":"2021","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.coph.2022.102345_bib47","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab085","article-title":"Humanin: a potential treatment for PCOS?","volume":"162","author":"Rodriguez Paris","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2022.102345_bib48","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/dom.14583","article-title":"Efficacy of canagliflozin versus metformin in women with polycystic ovary syndrome: a randomized, open-label, noninferiority trial","volume":"24","author":"Cai","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.coph.2022.102345_bib49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/cen.13968","article-title":"Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study","volume":"90","author":"Javed","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coph.2022.102345_sref50","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1210\/clinem\/dgab408","article-title":"Exenatide, dapagliflozin, or phentermine\/topiramate differentially Affect metabolic profiles in polycystic ovary syndrome","volume":"106","author":"Elkind-Hirsch","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102345_sref51","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/dom.14495","article-title":"Licogliflozin versus placebo in women with polycystic ovary syndrome: a randomized, double-blind, phase 2 trial","volume":"23","author":"Tan","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.coph.2022.102345_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.830401","article-title":"A\u00a0meta-analysis of the effect of Sodium glucose cotransporter-2 inhibitors on metabolic parameters in patients with polycystic ovary syndrome","volume":"13","author":"Sinha","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.coph.2022.102345_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","article-title":"Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study","volume":"118","author":"Elkind-Hirsch","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.coph.2022.102345_bib54","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists","volume":"105","author":"Cena","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coph.2022.102345_bib55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Han","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.coph.2022.102345_bib56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00429-020-02167-7","article-title":"Networking of glucagon-like peptide-1 axons with GnRH neurons in the basal forebrain of male mice revealed by 3DISCO-based immunocytochemistry and optogenetics","volume":"226","author":"Vastagh","year":"2021","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.coph.2022.102345_bib57","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2014-1978","article-title":"GLP-1 increases preovulatory LH source and the number of mature follicles, as well as synchronizing the onset of puberty in female rats","volume":"156","author":"Outeirino-Iglesias","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2022.102345_bib58","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/jog.13847","article-title":"Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-beta1 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats","volume":"45","author":"Wang","year":"2019","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.coph.2022.102345_bib59","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1080\/15384101.2019.1652036","article-title":"Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19","volume":"18","author":"Wang","year":"2019","journal-title":"Cell Cycle"},{"key":"10.1016\/j.coph.2022.102345_bib60","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz028","article-title":"Sitagliptin decreases visceral fat and blood glucose in women with polycystic ovarian syndrome","volume":"105","author":"Devin","year":"2020","journal-title":"J\u00a0Clin Endocrinol Metab"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489222001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:58:25Z","timestamp":1761461905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489222001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":60,"alternative-id":["S1471489222001722"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2022.102345","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in emerging PCOS therapies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2022.102345","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102345"}}